Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adastra Holdings Ltd (OP: XTXXF ) 0.0600 UNCHANGED Last Price Updated: 12:55 PM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Adastra Holdings Ltd Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses April 25, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Adastra Holdings Appoints Smoke Wallin As New Director May 16, 2022 Adastra Holdings Ltd. (OTCPK: XTXXF) (FRA: D2EP) appointed Smoke Wallin to the company's board of directors. Wallin Responds Via Benzinga Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2 August 18, 2023 Candian marijuana operator Adastra Holdings Ltd. (OTC: XTXXF)(CSE:XTRX)(FRA:D2EP) reported Thursday financial results for the three months ended June 30, 2023, disclosing net revenue of CA$7.1 million,... Via Benzinga Topics Cannabis Exposures Cannabis Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What's Behind The Figures? May 31, 2023 Cannabis producer Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTC: XTXXF) reported on Tuesday financial results for the three months ended March 31, 2023. Via Benzinga Adastra FY22 Revenue Grows 136%, Here Is What You Need To Know May 02, 2023 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) FY 2022 net revenue increased 136% to CA$13.3 million ($9.8 million), compared to CA$5.6 million in FY 2021. FY 2022 Financial Highlights Gross... Via Benzinga Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit March 16, 2023 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) has been served with a civil claim filed in the Supreme Court of British Columbia pursuant to the Class Proceedings Act, R.S.B.C. 1996, c. 50... Via Benzinga Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial Via Benzinga Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More March 07, 2023 Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... Via Benzinga Adastra Clarifies Health Canada Approval To Handle Cocaine March 06, 2023 Adastra Labs Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) provided clarification regarding its receipt of Health Canada approval for the amendment to include cocaine under its controlled substances... Via Benzinga Canadian Weed Company's Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment March 03, 2023 A Langley, British Columbia, cannabis company got the green light from Health Canada to produce and sell cocaine earlier this month, but the province's Premier says he was unaware of the mo Via Benzinga Canada Gives This Cannabis Company The Green Light To Handle Cocaine, Psilocybin February 23, 2023 Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTCPK: XTXXF) reported on Wednesday that Adastra Labs got the green light from Health Canada earlier this month for its amendment to include cocaine as a... Via Benzinga Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga Adastra Q3 Revenue Grows 110% YoY To $2.83M December 02, 2022 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP), released its financial results for the three and nine months ended September 30, 2022. Q3 2022 Financial Highlights Via Benzinga Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin August 31, 2022 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and... Via Benzinga Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies May 20, 2022 OnPoint Laboratories Names Samuel Richard CEO & Equity Partner OnPoint Laboratories has appointed Samuel Richard to serve as CEO and equity partner. Richard succeeds Jeff Cardot, founder and current... Via Benzinga Adastra Holdings Reports Record Revenue In 2021, Here Are The Details May 04, 2022 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021. Via Benzinga Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services April 11, 2022 Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the... Via Benzinga Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD March 25, 2022 Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE:XTRX) (FRA:... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.